262 related articles for article (PubMed ID: 9717955)
1. Tamoxifen in early breast cancer.
Benson JR
Lancet; 1998 Aug; 352(9125):404-5. PubMed ID: 9717955
[No Abstract] [Full Text] [Related]
2. Tamoxifen in early breast cancer.
Arriagada R
Lancet; 1998 Aug; 352(9125):403-4. PubMed ID: 9717953
[No Abstract] [Full Text] [Related]
3. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Narod S
J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
[No Abstract] [Full Text] [Related]
4. [Tamoxifen and breast cancer: is everything known already?].
Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
[No Abstract] [Full Text] [Related]
5. Tamoxifen in early breast cancer.
Bryce CJ
Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
[No Abstract] [Full Text] [Related]
6. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG
J Natl Cancer Inst; 1997 Nov; 89(22):1673-82. PubMed ID: 9390536
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of breast cancer.
O'Shaughnessy JA
JAMA; 1996 May; 275(17):1349-53. PubMed ID: 8614122
[No Abstract] [Full Text] [Related]
8. Tamoxifen therapy--long-term results and complications.
Moore MP; Kinne DW
Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
[No Abstract] [Full Text] [Related]
9. Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: a randomized study.
Gundersen S; Hannisdal E; Søreide JA; Skarstein A; Varhaug JE
Breast Cancer Res Treat; 1995; 36(1):49-53. PubMed ID: 7579506
[TBL] [Abstract][Full Text] [Related]
10. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
Trunet P; Marty M
Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
[TBL] [Abstract][Full Text] [Related]
11. The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?
Johnston SR; Yeo B
Curr Oncol Rep; 2014; 16(1):358. PubMed ID: 24390724
[TBL] [Abstract][Full Text] [Related]
12. Hormonal strategies for the prevention of breast cancer.
Olsen MR; Love RR
Cancer Treat Res; 1998; 94():135-57. PubMed ID: 9587686
[No Abstract] [Full Text] [Related]
13. Tamoxifen Breast Cancer Prevention Trial--an update.
Ford LG; Johnson KA
Prog Clin Biol Res; 1997; 396():271-82. PubMed ID: 9108604
[No Abstract] [Full Text] [Related]
14. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
Munster PN; Horton J
Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
[No Abstract] [Full Text] [Related]
15. Hormonal therapy of breast cancer.
Locker GY
Cancer Treat Rev; 1998 Jun; 24(3):221-40. PubMed ID: 9767736
[No Abstract] [Full Text] [Related]
16. Can mammographic densities predict effects of tamoxifen on the breast?
Ursin G; Pike MC; Spicer DV; Porrath SA; Reitherman RW
J Natl Cancer Inst; 1996 Jan; 88(2):128-9. PubMed ID: 8537975
[No Abstract] [Full Text] [Related]
17. Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen.
Martelli G; DePalo G; Rossi N; Coradini D; Boracchi P; Galante E; Vetrella G
Br J Cancer; 1995 Nov; 72(5):1251-5. PubMed ID: 7577477
[TBL] [Abstract][Full Text] [Related]
18. Current controversies in breast cancer management.
Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
[No Abstract] [Full Text] [Related]
19. Breast cancer highlights.
Kuter I
Oncologist; 1999; 4(4):299-308. PubMed ID: 10476541
[No Abstract] [Full Text] [Related]
20. [Basic Consensus on endocrinotherapy for breast cancer].
Jiang ZF; Xu BH; Song ST
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):238-9. PubMed ID: 16875616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
